newsfilter
← Latest News
GlobeNewswire·

Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update

Conference Call and Webcast Scheduled for May 13, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage